InsidersTradesSigma
Track the Zealand Pharma A/S share price and the full directors' dealings record of the company, a listed equity based in Denmark. Shares are quoted on the DK market, under the authority of Finanstilsynet DK. Operating in the Healthcare & Pharma sector, Zealand Pharma A/S has recorded 59 reports. Market capitalisation: €22.2bn. The latest transaction was reported on 28 August 2026 (Sale). The full history is openly available.
59
Insider Decl.
n/a
Thresholds
€341,229
5 ops.
Buy Volume
€6m
19 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Zealand Pharma A/S Buy (bullish), based on 14 analysts. Average price target: DKK 441.93.
25Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27 of 28,958 companies
94.8
score / 100
Value97
Quality93
FCF yld30%
Earn yld30%
EV/EBITDA3.1x
ROE16%
Gross mgn100%
Net mgn70%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 August 2026
Declarations59 total
309 shares@ DKK 324.60ShareDanske Bank System Internalizer, DASIISIN DK0060257814DK:1460884
646 shares@ DKK 300.590.0010% mcap8.9% of flowShareNasdaq Copenhagen, XCSEISIN DK0060257814DK:1455013
1,000 shares@ DKK 278.000.0013% mcap14.0% of flowShareNasdaq Copenhagen, XCSEISIN DK0060257814DK:1449295
4,547 shares@ DKK 90.700.0019% mcap24.2% of flowShareOutside a trading venue, XOFFISIN DK0060257814DK:1447494
4,000 shares@ DKK 322.800.0060% mcap100.0% of flowShareOutside a trading venue, XOFFISIN DK0060257814DK:1445443
29,403 shares@ DKK 316.29060.043% mcap2.6% of flowShareOutside a trading venue, XOFFISIN DK0060257814DK:1436237
1,500 shares@ DKK 329.300.0023% mcap0.1% of flowShareOutside a trading venue, XOFFISIN DK0060257814DK:1435190
1 shares@ DKK 467.000.0000% mcap0.0% of flowShareNasdaq Copenhagen, XCSEISIN DK0060257814DK:1407692
15,442 shares@ DKK 487.600.035% mcap2.1% of flowShareOutside a trading venue, XOFFISIN DK0060257814DK:1404877
106,680 shares@ DKK 408.900.20% mcap12.3% of flowShareOutside a trading venue, XOFFISIN DK0060257814DK:1366074
1,217 shares@ DKK 424.500.0024% mcap0.1% of flowShareOutside a trading venue, XOFFISIN DK0060257814DK:1356822
1,090 shares0ShareOutside a trading venue, XOFFISIN DK0060257814DK:1337157
ShareDK:1335333
1,000 shares@ DKK 850.000.0040% mcap0.2% of flowShareNasdaq Copenhagen (OMX)ISIN DK0060257814DK:1327123
35,000 shares@ DKK 878.000.14% mcap8.7% of flowShareNasdaq CopenhagenISIN DK0060257814DK:1314117
12 shares0.96% mcap57.9% of flowShareOutside trading VenueISIN DK0060257814DK:1294926
8,008 shares@ DKK 598.000.022% mcap1.3% of flowShareOutside the marketISIN DK0060257814DK:1289217
854 shares@ DKK 598.000.0024% mcap0.1% of flowShareOutside the marketISIN DK0060257814DK:1289173
2,000 shares@ DKK 712.000.0067% mcap0.4% of flowShareNasdaq CopenhagenISIN DK0060257814DK:1284047
500 shares@ DKK 699.000.0016% mcap0.1% of flowShareNasdaq CopenhagenISIN DK0060257814DK:1282221
1,000 shares@ DKK 739.000.0035% mcap0.2% of flowShareNasdaq CopenhagenISIN DK0060257814DK:1280108
8,401 shares@ DKK 138.600.0054% mcap0.3% of flowShareOutside trading venueISIN DK0060257814DK:1279394
1,800 shares@ DKK 351.110.0030% mcap0.2% of flowShareNasdaq CopenhagenISIN DK0060257814DK:1263706
2 shares@ DKK 3,399,409.000.032% mcap1.9% of flowShareOutside trading VenueISIN DK0060257814DK:1262781
1,500 shares@ DKK 224.400.0016% mcap0.1% of flowShareOutside trading venueISIN DK0060257814DK:1247975
25 of 59 declarations
About Zealand Pharma A/S
Zealand Pharma A/S is a Danish biopharmaceutical company focused on developing treatments for metabolic and endocrine diseases. It emphasizes innovation in the field of therapeutic peptides.
